This is a permanent results page for your analyzed data. Please save the link in your browser's address bar.
| Title / Description | Peripheral blood mononuclear cells response to Lassa Virus and Mopeia/Lassa reassortant 29: time course |
| Accession | GDS5058 |
| Summary | Analysis of PBMCs exposed in vitro to LASV or ML29 viruses and collected up to 24 hrs post-exposure. The ML29 vaccine candidate is derived from Lassa and Mopeia viruses and protects against Lassa fever disease. Results provide insight into LASV-induced pathology and mechanisms of attenuation. |
| Organism | Homo sapiens |
| Platform | GPL570 |
| Normalized | False |
| Parsed SOFT file |
| Differential expression method | Characteristic Direction |
| Cutoff | 500 |
| Microbe_name | Mopeia/Lassa reassortant 29 (ML29) |
| Cell_type | peripheral blood mononuclear cells (PBMC) |
| Organism | human |
| Gene lists | Enrichr | L1000CDS2 | PAEA | Crowdsourcing | |
| Up |
|
||||
| Down |
|
||||
| Combined |
|
|
|
|
